hence the fall
I honestly didn't think that many people were expecting a priority review. Very frustrating....AMRN is doing everything they have control over.
They gave the sNDA a quick acceptance, typically they take 60+ days. This was early.
no NCE, no priority review.. Looks AMRN is FDA's red headed stepchild, no offense to any of you resembling this, lol
why is FDA suddenly getting irritated with Amarin? they could have put a priority review for Anchor since there is no available medicine for that population?